First-time surgical aortic valve replacement: nationwide trends and outcomes from The Netherlands Heart Registration
European Journal of Cardio-Thoracic Surgery · 03.05.2024 · 65 (5)
DOI: 10.1093/ejcts/ezae177 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 10.05.2024. Verfasst von Edgar J Daeter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, Netherlands. Hauptthemen laut MEDLINE: Aortic Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES The aim of this study was to describe trends and outcomes for patients undergoing surgical aortic valve replacement (SAVR) in the Netherlands. METHODS The Netherlands Heart Registration database was used to report the number and outcomes of isolated, primary SAVR procedures performed from 2007 to 2018 in adult patients. RESULTS A total of 17 142 procedures were included, of which 77.9% were performed using a biological prosthesis and 21.0% with a mechanical prosthesis. Median logistic EuroSCORE I decreased from 4.6 [interquartile range (IQR) 2.4–7.7] to 4.0 (IQR 2.6–6.0). The 120-day mortality decreased from 3.3% in 2007 to 0.7% in 2018. The median duration of follow-up was 76 months (IQR 53–111). Ten-year survival, when adjusted for age, EuroSCORE I and body surface area, was 72.4%, and adjusted 10-year freedom from reinvervention was 98.1%. Additional analysis for patients under the age of 60 showed no difference between patients treated with a biological or mechanical prosthesis in adjusted 10-year survival, 89.7% vs 91.9±%, respectively (P = 0.25), but a significant difference in adjusted 10-year freedom from reintervention, 90.0±% vs 95.9%, respectively (P < 0.01). CONCLUSIONS Between 2007 and 2018, age and risk profile of patients undergoing SAVR decreased, especially for patients treated with a biological prosthesis. The 120-day mortality decreased over time. Patients undergoing SAVR nowadays have a risk of 120-day mortality of <1% and 10-year freedom from valve-related reintervention of >95%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, Netherlands.
- Netherlands Heart Registration, Utrecht, Netherlands.
- Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands.
- Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, Netherlands.
ORCID-Profile: Hector W L de Beaufort
Zitieren
APA
Daeter, E. J., de Beaufort, H. W. L., Roefs, M. M., van Boven, W. J. P., van Veghel, D., van der Kaaij, N. P., & Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration (2024). First-time surgical aortic valve replacement: nationwide trends and outcomes from The Netherlands Heart Registration. European Journal of Cardio-Thoracic Surgery, 65(5). https://doi.org/10.1093/ejcts/ezae177
Vancouver
Daeter EJ, de Beaufort HWL, Roefs MM, van Boven WJP, van Veghel D, van der Kaaij NP, et al. First-time surgical aortic valve replacement: nationwide trends and outcomes from The Netherlands Heart Registration. European Journal of Cardio-Thoracic Surgery. 2024;65(5). doi:10.1093/ejcts/ezae177
BibTeX
@article{Daeter2024,
author = {Daeter, Edgar J and de Beaufort, Hector W L and Roefs, Maaike M and van Boven, Wim Jan P and van Veghel, Dennis and van der Kaaij, Niels P and Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration, Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration},
title = {First-time surgical aortic valve replacement: nationwide trends and outcomes from The Netherlands Heart Registration},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {65},
number = {5},
doi = {10.1093/ejcts/ezae177}
}
EUVIMED